South San Francisco biotechnology company Renovis, which slashed its workforce in January after one of its drug candidates flopped a major test, said Wednesday it has agreed to be purchased for $151.
From: www.mercurynews.com
Thursday, September 20, 2007
German drug maker to acquire Renovis
Subscribe to:
Post Comments (Atom)
![Digitalpoint Geo Tracking [Enabled]](http://geo.digitalpoint.com/a.png)
![PingOmatic AutoDiscovery [Enabled]](http://www.genuineblogger.com/images/chicklet-pingomatic.gif)
![Made with Palestinian Efforts [True]](http://www.genuineblogger.com/images/yapalestinets.gif)
No comments:
Post a Comment